Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. - Test2 - elhamkhani - TriplyDB

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

http://www.wikidata.org/entity/Q37033793

about

Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature Convex probe endobronchial ultrasound: applications beyond conventional indications The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis.A case report of local treatment of inoperable squamous cell lung carcinoma with convex-probe endobronchial ultrasound-guided intratumoral injection of cisplatin in a patient with severe COPD.Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer.Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay DDMC-p53 gene therapy with or without cisplatin and microwave ablation.Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System.Albumin-Gold Nanorod Nanoplatform for Cell-Mediated Tumoritropic Delivery with Homogenous ChemoDrug Distribution and Enhanced Retention Ability Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.

P2860

Q26766244-57F51A62-68D2-4E87-9578-AF5BB50328AF Q26778709-920966B2-2255-4001-AD53-A811B64D193C Q33736218-860A554E-FADF-4778-AFED-197C9891A91E Q33789403-E5425533-2861-4D6B-8BD5-397C0B47BAE9 Q33818023-F79F4EE3-4368-42B7-9B6F-D877A0075045 Q35051258-149EB5AF-A699-4501-AA8A-F9A54D5BE640 Q35652859-E5C88C97-2A57-489F-BE9C-E49DB1A6AC71 Q35654976-B64AF009-1988-48CF-9796-3680061127D2 Q38689201-E94C5A80-BF76-460B-BD4A-BF8ECFDA54C2 Q38945119-CC1B53CC-2081-4C50-BD5F-0D712E89E880 Q44723040-3531D798-D51B-424D-B745-BBF58CD6434B Q52722299-8AC25E2B-E1B1-49F3-A9C4-448239015E16

P2860

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

http://www.wikidata.org/entity/Q37033793

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@en

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@nl

type

label

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@en

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@nl

prefLabel

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@en

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@nl

P1433

Q37033793-33DF43EE-CCC0-4A87-A234-0BF455973460

P1476

Q37033793-71595AD2-A5ED-4AB9-8366-C31976630886

P2093

Q37033793-06220B5A-4796-4A31-A8DA-B660BDB259EC

Q37033793-0AC69850-E3BB-4E82-B0DD-4C6E5FD28D74

Q37033793-12E6EA6F-1DCB-4483-8055-8571AB488792

Q37033793-1E18ADEB-8764-43B7-B8A0-04D62717210B

Q37033793-2C17F5B5-5B3C-4146-BA65-026B85E28AA2

Q37033793-330D3010-A145-40F9-A26E-56B315BFDFF3

Q37033793-4568CB0A-ADFB-4C95-9977-93FCBC4810F1

Q37033793-6544C143-2644-4925-83B1-626EB880B48F

Q37033793-7424FB14-1DF2-45C2-B1E1-EC06CD24EDDC

Q37033793-77DA3992-AC97-4F44-B005-523B28A40C37

P2860

Q37033793-0B90722A-FF86-4799-BD51-BC88CBD8E7D0

Q37033793-0E3A5333-60B7-44F1-8A53-EF1C6AFC2683

Q37033793-10CE1B02-6900-42A6-9E7C-930FE7A500B9

Q37033793-1BE1B912-4701-4F71-B851-ECFD9B089277

Q37033793-1C868DC8-B2B9-4399-BDA4-8BCB8517DA02

Q37033793-1CB03369-FFE8-4798-83C7-291946E8AE48

Q37033793-1CD1E9A8-F04F-408B-AE3D-83A95260B93A

Q37033793-1D6F77BE-E788-4FEA-91C5-8F638EB8D8FF

Q37033793-222D604F-8968-4C57-95EE-E0F72F4B7645

Q37033793-28B1D403-66BE-48DD-B8D4-78617D471A51

P304

Q37033793-904B34D2-FDD6-4BD1-B0D1-C0F6F9D065F4

P31

Q37033793-EA275C43-D91B-447B-A8F3-EFE00880608B

P356

Q37033793-14C8AFEB-0C96-4DC9-BEDD-D40BE118311F

P407

Q37033793-1AC5BAF9-08DF-48B8-B264-890C318E2416

P478

Q37033793-F9F79ABA-BC6C-4DFD-A620-1C42D902AA4B

P577

Q37033793-13645BBD-84D4-4418-82C2-E6AA03921720

P5875

Q37033793-912280CE-09DA-4DCB-B6B0-38F861522F69

P698

Q37033793-73A1B231-66B3-49D8-BCEC-98518D22E30E

P921

Q37033793-62910C01-AF19-423E-86FE-7495D1F956EB

P932

Q37033793-91536557-D4E0-491E-A102-2701C5A70630

P356

P1433

Drug Design, Development and Therapy

P1476

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.

@en

P2093

Dionysios Spyratos

http://www.w3.org/2001/XMLSchema#string

Eugene P Goldberg

http://www.w3.org/2001/XMLSchema#string

Firuz Celikoglu

http://www.w3.org/2001/XMLSchema#string

Francis J Turner

http://www.w3.org/2001/XMLSchema#string

Haidong Huang

http://www.w3.org/2001/XMLSchema#string

Johannes Brachmann

http://www.w3.org/2001/XMLSchema#string

Kaid Darwiche

http://www.w3.org/2001/XMLSchema#string

Konstantinos Zarogoulidis

http://www.w3.org/2001/XMLSchema#string

Michael Simoff

http://www.w3.org/2001/XMLSchema#string

Patrick Le Pivert

http://www.w3.org/2001/XMLSchema#string

P2860

Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth

Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors

A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for Eastern Asian nonsquamous non-small-cell lung cancer

Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948)

Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors.

Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma.

Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer.

Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer.

Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension.

Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.

P304

571-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S46393

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253339955

http://www.w3.org/2001/XMLSchema#string

P698

23898222

http://www.w3.org/2001/XMLSchema#string

P921

P932

3718837

http://www.w3.org/2001/XMLSchema#string